DiscoveryBioMed's scientific expertise has developed over many years of human cell physiology research.

Our laboratory is equipped with a state-of-the-art cell culture and engineering facility. Coupled to that, we have high-throughput molecular screening (HTS) capability with all types of luminescence, fluorescence, and absorbance detection. These facilities provide the means to perform many different high-throughput bioassays on human and mammalian cell-based platforms.

Our compound libraries come from diverse synthetic and natural-product sources. The selection of these libraries is guided by our company's expertise in physiology and biochemistry. DBM has more than 75,000 small molecules as well as phytochemical extracts available to test on each endpoint, target, pathway or system.

DBM's philosophy is that the best molecular screening approach to drug discovery is to utilize in vitro cell lines or primary cultures (preferably, human) that are as close to in vivo conditions as possible. Its diseased and wild-type cell lines are engineered to retain phenotypes through many cycles of cell division, leading to reliable results from cell screening assays.

In its own discovery work using the same infrastructure as its 'services' business, DBM brings the same expertise, tools, and philosophy to bear on identifying compounds with promise as therapeutics for respiratory, metabolic, inflammatory and hyperproliferative human and veterinary diseases.